Androgen deprivation therapy (ADT) is a treatment used across the prostate cancer disease spectrum and works by suppressing testicular androgen production to castrate levels. Although ADT can provide survival benefits, it is also associated with increased risk for cardiovascular disease, metabolic syndrome, increased visceral fat mass, dyslipidemia, decreased arterial compliance, and diminished health-related quality of life. The Staying Strong And Healthy protocol is a telephone-delivered intervention led by a nurse coordinator to minimize the increased cardiovascular and metabolic risks associated with ADT. This study will evaluate the feasibility of the protocol and provides the foundation for future behavioral interventions across diverse populations of men on ADT.

CONFLICT OF INTERESTS

The authors declare that there is no conflict of interests that could be perceived as prejudicing the impartiality of the research reported.

REFERENCES

Alibhai, S. M. H., Breunis, H., Timilshina, N., Naglie, G., Tannock, I., Krahn, M., … Tomlinson, G. (2015). Long-term impact of androgen-deprivation therapy on physical function and quality of life. Cancer, 121(14), 2350–2357. https://doi.org/10.1002/cncr.29355
10.1002/cncr.29355
CAS PubMed Web of Science® Google Scholar
American Cancer Society. (2018). Key statistics for prostate cancer. Retrieved from https://www.cancer.org/cancer/prostate-cancer/about/key-statistics.html
Google Scholar
American College of Sports Medicine, Thompson, W. R., Gordon, N. F., & Pescatello, L. S. (2010). ACSM's guidelines for exercise testing and prescription ( 8th ed.). Philadelphia: Lippincott Williams & Wilkins.
Web of Science® Google Scholar
Baguley, B., Bolam, K., Wright, O., & Skinner, T. (2017). The effect of nutrition therapy and exercise on cancer-related fatigue and quality of life in men with prostate cancer: A systematic review. Nutrients, 9(9), 1003. https://doi.org/10.3390/nu9091003
10.3390/nu9091003
PubMed Web of Science® Google Scholar
Bandura, A. (2004). Health promotion by social cognitive means. Health Education & Behavior: The Official Publication of the Society for Public Health Education, 31(2), 143–164. https://doi.org/10.1177/1090198104263660
10.1177/1090198104263660
PubMed Web of Science® Google Scholar
Bhandari, N. R., Kathe, N., Hayes, C., & Payakachat, N. (2018). Reliability and validity of SF-12v2 among adults with self-reported cancer. Research in Social and Administrative Pharmacy, 14(11), 1080–1084. https://doi.org/10.10/16/j.sapharm.2018.01.007
10.1016/j.sapharm.2018.01.007
PubMed Web of Science® Google Scholar
Bourke, L., Doll, H., Crank, H., Daley, A., Rosario, D., & Saxton, J. M. (2011). Lifestyle intervention in men with advanced prostate cancer receiving androgen suppression therapy: A feasibility study. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 20(4), 647–657. https://doi.org/10.1158/1055-9965.EPI-10-1143
10.1158/1055-9965.EPI-10-1143
PubMed Web of Science® Google Scholar
Bourke, L., Gilbert, S., Hooper, R., Steed, L. A., Joshi, M., Catto, J. W. F., … Rosario, D. J. (2014). Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: A randomised controlled trial. European Urology, 65(5), 865–872. https://doi.org/10.1016/j.eururo.2013.09.040
10.1016/j.eururo.2013.09.040
PubMed Web of Science® Google Scholar
Braunstein, L. Z., Chen, M. H., Loffredo, M., Kantoff, P. W., & D'Amico, A. V. (2014). Obesity and the odds of weight gain following androgen deprivation therapy for prostate cancer. Prostate Cancer, 2014, 1–6. https://doi.org/10.1155/2014/230812
10.1155/2014/230812
Google Scholar
Buffart, L. M., Galvão, D. A., Chinapaw, M. J., Brug, J., Taaffe, D. R., Spry, N., … Newton, R. U. (2014). Mediators of the resistance and aerobic exercise intervention effect on physical and general health in men undergoing androgen deprivation therapy for prostate cancer. Cancer, 120(2), 294–301. https://doi.org/10.1002/cncr.28396
10.1002/cncr.28396
PubMed Web of Science® Google Scholar
Carlsson, S., Drevin, L., Loeb, S., Widmark, A., Lissbrant, I. F., Robinson, D., … Fransson, P. (2016). Population-based study of long-term functional outcomes after prostate cancer treatment. BJU International, 117(6B), E36–E45. https://doi.org/10.1111/bju.13179
10.1111/bju.13179
CAS PubMed Web of Science® Google Scholar
Centers for Disease Control and Prevention. (2017). About adult BMI. Retrieved from https://www.cdc.gov/healthyweight/assessing/bmi/adult_bmi/index.html
Google Scholar
Cormie, P., Galvão, D. A., Spry, N., Joseph, D., Chee, R., Taaffe, D. R., … Newton, R. U. (2015). Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: A randomised controlled trial. BJU International, 115(2), 256–266. https://doi.org/10.1111/bju.12646
10.1111/bju.12646
PubMed Web of Science® Google Scholar
Donovan, K. A., Walker, L. M., Wassersug, R. J., Thompson, L. M. A., & Robinson, J. W. (2015). Psychological effects of androgen-deprivation therapy on men with prostate cancer and their partners. Cancer, 121, 4286–4299. https://doi.org/10.1002/cncr.29672
10.1002/cncr.29672
CAS PubMed Web of Science® Google Scholar
Dorff, T. B., Gross, M. E., Quinn, D. I., Pinski, J. K., Schroeder, E. T., Groshen, S. G., … Kiwata, J. (2017). Impact of resistance exercise on metabolic syndrome (MetS) parameters in men receiving androgen deprivation therapy (ADT) for prostate cancer. Journal of Clinical Oncology, 35(suppl 6), 223. https://doi.org/10.1200/JCO.2017.35.6_suppl.223
10.1200/JCO.2017.35.6_suppl.223
Web of Science® Google Scholar
Eckel, R. H., Jakicic, J. M., Ard, J. D., de Jesus, J. M., Houston Miller, N., Hubbard, V. S., … Yanovski, S. Z. (2014). 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk. Journal of the American College of Cardiology, 63(25 Part B), 2960–2984. https://doi.org/10.1016/j.jacc.2013.11.003
10.1016/j.jacc.2013.11.003
PubMed Web of Science® Google Scholar
Freedland, S. J., Howard, L., Allen, J., Smith, J., Stout, J., Aronson, W., … Lin, P. H. (2019). A lifestyle intervention of weight loss via a low-carbohydrate diet plus walking to reduce metabolic disturbances caused by androgen deprivation therapy among prostate cancer patients: Carbohydrate and prostate study 1 (CAPS 1) randomized controlled trial. Prostate Cancer and Prostatic Diseases, https://doi.org/10.1038/s41391-019-0126-5. Advance online publication
10.1038/s41391-019-0126-5
Web of Science® Google Scholar
Galvão, D. A., Taaffe, D. R., Spry, N., Joseph, D., & Newton, R. U. (2010). Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: A randomized controlled trial. Journal of Clinical Oncology, 28(2), 340–347. https://doi.org/10.1200/JCO.2009.23.2488
10.1200/JCO.2009.23.2488
CAS PubMed Web of Science® Google Scholar
Gonzalez, B. D., Jim, H. S. L., Booth-Jones, M., Small, B. J., Sutton, S. K., Lin, H. Y., … Jacobsen, P. B. (2015). Course and predictors of cognitive function in patients with prostate cancer receiving androgen-deprivation therapy: A controlled comparison. Journal of Clinical Oncology, 33(18), 2021–2027. https://doi.org/10.1200/JCO.2014.60.1963
10.1200/JCO.2014.60.1963
PubMed Web of Science® Google Scholar
Van Hemelrijck, M., Garmo, H., Holmberg, L., Ingelsson, E., Bratt, O., Bill-Axelson, A., … Adolfsson, J. (2010). Absolute and relative risk of cardiovascular disease in men with prostate cancer: Results from the population-based PCBaSe Sweden. Journal of Clinical Oncology, 28(21), 3448–3456. https://doi.org/10.1200/jco.2010.29.1561
10.1200/JCO.2010.29.1567
PubMed Web of Science® Google Scholar
Hou, X., & Flaig, T. W. (2012). Redefining hormone sensitive disease in advanced prostate cancer. Advances in Urology, 2012, 978531. https://doi.org/10.1155/2012/978531
10.1155/2012/978531
PubMed Google Scholar
Keating, N. L., O'Malley, A., Freedland, S. J., & Smith, M. R. (2012). Diabetes and cardiovascular disease during androgen deprivation therapy: Observational study of veterans with prostate cancer. Journal of the National Cancer Institute, 104(19), 1518–1523. https://doi.org/10.1093/jnci/djs376
PubMed Web of Science® Google Scholar
Knols, R., Aaronson, N. K., Uebelhart, D., Fransen, J., & Aufdemkampe, G. (2005). Physical exercise in cancer patients during and after medical treatment: A systematic review of randomized and controlled clinical trials. Journal of Clinical Oncology, 23(16), 3830–3842. https://doi.org/10.1200/JCO.2005.02.148
10.1200/JCO.2005.02.148
PubMed Web of Science® Google Scholar
Lee, M., Jim, H. S., Fishman, M., Zachariah, B., Heysek, R., Biagioli, M., & Jacobsen, P. B. (2015). Depressive symptomatology in men receiving androgen deprivation therapy for prostate cancer: A controlled comparison. Psycho-oncology, 24(4), 472–477. https://doi.org/10.1002/pon.3608
10.1002/pon.3608
PubMed Web of Science® Google Scholar
Levine, G. N., D'Amico, A. V., Berger, P., Clark, P. E., Eckel, R. H., Keating, N. L., … American Heart Association Council on Clinical Cardiology and Council on Epidemiology and Prevention, the American Cancer Society, and the American Urological Association (2010). Androgen-deprivation therapy in prostate cancer and cardiovascular risk: A science advisory from the American Heart Association, American Cancer Society, and American Urological Association: Endorsed by the American Society for Radiation Oncology. CA: A Cancer Journal for Clinicians, 60(3), 194–201. https://doi.org/10.3322/caac.20061
10.3322/caac.20061
PubMed Web of Science® Google Scholar
van Londen, G. J., Levy, M. E., Perera, S., Nelson, J. B., & Greenspan, S. L. (2008). Body composition changes during androgen deprivation therapy for prostate cancer: A 2-year prospective study. Critical Reviews in Oncology/Hematology, 68(2), 172–177. https://doi.org/10.1016/j.critrevonc.2008.06.006
10.1016/j.critrevonc.2008.06.006
PubMed Web of Science® Google Scholar
Maliski, S. L., Rivera, S., Connor, S., Lopez, G., & Litwin, M. S. (2008). Renegotiating masculine identity after prostate cancer treatment. Qualitative Health Research, 18(12), 1609–1620. https://doi.org/10.1177/1049732308326813
10.1177/1049732308326813
PubMed Web of Science® Google Scholar
Nguyen, P. L., Alibhai, S. M. H., Basaria, S., D'Amico, A. V., Kantoff, P. W., Keating, N. L., … Smith, M. R. (2015). Adverse effects of androgen deprivation therapy and strategies to mitigate them. European Urology, 67(5), 825–836. https://doi.org/10.1016/j.eururo.2014.07.010
10.1016/j.eururo.2014.07.010
CAS PubMed Web of Science® Google Scholar
NHLBI Obesity Education Initiative Expert Panel on the Identification, Evaluation, and Treatment of Obesity in Adults (US). (1998). Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. Bethesda (MD): National Heart, Lung, and Blood Institute. (Report No. 98-4083). https://www.ncbi.nlm.nih.gov/books/NBK2004/
Google Scholar
O'Neill, R. F., Haseen, F., Murray, L. J., O'sullivan, J. M., & Cantwell, M. M. (2015). A randomised controlled trial to evaluate the efficacy of a 6-month dietary and physical activity intervention for patients receiving androgen deprivation therapy for prostate cancer. Journal of Cancer Survivorship, 9(3), 431–440. https://doi.org/10.1007/s11764-014-0417-8
10.1007/s11764-014-0417-8
PubMed Web of Science® Google Scholar
Pagliarulo, V., Bracarda, S., Eisenberger, M. A., Mottet, N., Schröder, F. H., Sternberg, C. N., & Studer, U. E. (2012). Contemporary role of androgen deprivation therapy for prostate cancer. European Urology, 61(1), 11–25. https://doi.org/10.1016/j.eururo.2011.08.026
10.1016/j.eururo.2011.08.026
CAS PubMed Web of Science® Google Scholar
Punnen, S., Cooperberg, M. R., D'Amico, A. V., Karakiewicz, P. I., Moul, J. W., Scher, H. I., … Freedland, S. J. (2013). Management of biochemical recurrence after primary treatment of prostate cancer: A systematic review of the literature. European Urology, 64(6), 905–915. https://doi.org/10.1016/j.eururo.2013.05.025
10.1016/j.eururo.2013.05.025
PubMed Web of Science® Google Scholar
Salminen, E. K., Portin, R. I., Koskinen, A., Helenius, H., & Nurmi, M. (2004). Associations between serum testosterone fall and cognitive function in prostate cancer patients. Clinical Cancer Research, 10(22), 7575–7582. https://doi.org/10.1158/1078-0432.CCR-04-0750
10.1158/1078-0432.CCR-04-0750
CAS PubMed Web of Science® Google Scholar
Salvador, C., Planas, J., Agreda, F., Placer, J., Trilla, E., Lopez, M. A., & Morote, J. (2013). Analysis of the lipid profile and atherogenic risk during androgen deprivation therapy in prostate cancer patients. Urologia Internationalis, 90(1), 41–44. https://doi.org/10.1159/000342814
10.1159/000342814
CAS PubMed Web of Science® Google Scholar
Segal, R. J., Reid, R. D., Courneya, K. S., Malone, S. C., Parliament, M. B., Scott, C. G., … Wells, G. A. (2003). Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. Journal of Clinical Oncology, 21(9), 1653–1659. https://doi.org/10.1200/JCO.2003.09.534
10.1200/JCO.2003.09.534
PubMed Web of Science® Google Scholar
Sevilla, C., Maliski, S. L., Kwan, L., Connor, S. E., & Litwin, M. S. (2012). Long-term quality of life in disadvantaged men with prostate cancer on androgen deprivation therapy. Prostate Cancer and Prostatic Diseases, 15(3), 237–243. https://doi.org/10.1038/pcan.2011.71
10.1038/pcan.2011.71
CAS PubMed Web of Science® Google Scholar
Shahinian, V. B., Kuo, Y., Freeman, J. L., Orihuela, E., & Goodwin, J. S. (2005). Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma. Cancer, 103(8), 1615–1624. https://doi.org/10.1002/cncr.20955
10.1002/cncr.20955
CAS PubMed Web of Science® Google Scholar
Sharifi, N., Gulley, J. L., & Dahut, W. L. (2005). Androgen deprivation therapy for prostate cancer. Journal of the American Medical Association, 294(2), 238–244. https://doi.org/10.1001/jama.294.2.238
10.1001/jama.294.2.238
CAS PubMed Web of Science® Google Scholar
Shim, J. S., Oh, K., & Kim, H. C. (2014). Dietary assessment methods in epidemiologic studies. Epidemiology and Health, 36):e2014009. https://doi.org/10.4178/epih/e2014009
10.4178/epih/e2014009
PubMed Google Scholar
Taylor, L. G., Canfield, S. E., & Du, X. L. (2009). Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer. Cancer, 115(11), 2388–2399. https://doi.org/10.1002/cncr.24283
10.1002/cncr.24283
PubMed Web of Science® Google Scholar
Tsang, V. W., Skead, C., Wassersug, R. J., & Palmer-Hague, J. L. (2019). Impact of prostate cancer treatments on men's understanding of their masculinity. Psychology of Men & Masculinities, 20(2), 215–225. https://doi.org/10.1037/men0000184
10.1037/men0000184
Web of Science® Google Scholar
Wall, B. A., Galvão, D. A., Fatehee, N., Taaffe, D. R., Spry, N., Joseph, D., … Newton, R. U. (2017). Exercise Improves V˙O2max and body composition in androgen deprivation therapy–treated prostate cancer patients. Medicine & Science in Sports & Exercise, 49(8), 1503–1510. https://doi.org/10.1249/MSS.0000000000001277
10.1249/MSS.0000000000001277
PubMed Web of Science® Google Scholar
Wassersug, R. J. (2009). Mastering emasculation. Journal of Clinical Oncology, 27(4), 634–636. https://doi.org/10.1200/JCO.2008.20.1947
10.1200/JCO.2008.20.1947
PubMed Web of Science® Google Scholar
Wei, J. T., Dunn, R. L., Litwin, M. S., Sandler, H. M., & Sanda, M. G. (2000). Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology, 56(6), 899–905. https://www.ncbi.nlm.nih.gov/pubmed/11113727
10.1016/S0090-4295(00)00858-X
CAS PubMed Web of Science® Google Scholar
Wiseman, M. (2008). The Second World Cancer Research Fund/American Institute for Cancer Research Expert Report. Food, nutrition, physical activity, and the prevention of cancer: A global perspective. Proceedings of the Nutrition Society, 67(3), 253–256. https://doi.org/10.1017/S002966510800712X
10.1017/S002966510800712X
PubMed Web of Science® Google Scholar
World Cancer Research Fund International/American Institute for Cancer Research Continuous Update Project Report: Diet, Nutrition, Physical Activity, and Prostate Cancer. (2014). Retrieved from www.wcrf.org/sites/default/files/Prostate-Cancer-2014-Report.pdf
Google Scholar
Wu, L. M., Tanenbaum, M. L., Dijkers, M. P., Amidi, A., Hall, S. J., Penedo, F. J., & Diefenbach, M. A. (2016). Cognitive and neurobehavioral symptoms in patients with non-metastatic prostate cancer treated with androgen deprivation therapy or observation: A mixed methods study. Social Science & Medicine (1982), 156, 80–89. https://doi.org/10.1016/j.socscimed.2016.03.016
10.1016/j.socscimed.2016.03.016
PubMed Web of Science® Google Scholar
Yunfeng, G., Weiyang, H., Xueyang, H., Yilong, H., & Xin, G. (2017). Exercise overcome adverse effects among prostate cancer patients receiving androgen deprivation therapy: An update meta-analysis. Medicine, 96(27):e7368. https://doi.org/10.1097/MD.0000000000007368
10.1097/MD.0000000000007368
PubMed Web of Science® Google Scholar
Zavala, M. W., Maliski, S. L., Kwan, L., Miller, D. C., Fink, A., & Litwin, M. S. (2008). Longitudinal quality of life in low-income men in a state-funded prostate cancer treatment program. Journal of Health Care for the Poor and Underserved, 19(1), 200–214. https://doi.org/10.1353/hpu.2008.0026
10.1353/hpu.2008.0026
PubMed Web of Science® Google Scholar

Citing Literature

Volume42, Issue5

October 2019

Pages 324-333

Feasibility of an intervention for men on androgen deprivation therapy: A research protocol

Abstract

CONFLICT OF INTERESTS

REFERENCES

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Feasibility of an intervention for men on androgen deprivation therapy: A research protocol

Abstract

CONFLICT OF INTERESTS

REFERENCES

Citing Literature

References

Related

Information